Home1228 • HKG
add
Canbridge Pharmaceuticals Inc
Previous close
$1.86
Year range
$0.095 - $2.30
Market cap
790.20M HKD
Avg Volume
17.98M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 20.15M | -32.62% |
Operating expense | 73.06M | -27.38% |
Net income | -97.68M | -21.58% |
Net profit margin | -484.63 | -80.43% |
Earnings per share | — | — |
EBITDA | -56.92M | 27.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.50M | -92.36% |
Total assets | 116.81M | -70.45% |
Total liabilities | 591.30M | 35.88% |
Total equity | -474.49M | — |
Shares outstanding | 424.56M | — |
Price to book | -1.66 | — |
Return on assets | -129.75% | — |
Return on capital | 44.75% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -97.68M | -21.58% |
Cash from operations | -7.05M | 86.98% |
Cash from investing | -38.00K | 99.68% |
Cash from financing | -15.24M | -132.89% |
Net change in cash | -22.50M | 69.23% |
Free cash flow | -30.96M | 48.94% |
About
Founded
2012
Website
Employees
67